Headline News about Gilead Sciences
Unveiling 10 Analyst Insights On Gilead Sciences
Today 10:00 EDT
Via Benzinga
Gilead Sciences Options Trading: A Deep Dive into Market Sentiment
September 03, 2024
Via Benzinga
Via Benzinga
Via Benzinga
Peering Into Gilead Sciences's Recent Short Interest
August 20, 2024
Via Benzinga
Expert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
August 15, 2024
Via Benzinga
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
August 15, 2024
Via Benzinga
Exposures
Product Safety
Gilead Sciences's Options Frenzy: What You Need to Know
July 30, 2024
Via Benzinga
Gilead Sciences (GILD) Q2 2024 Earnings Call Transcript
August 08, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|